Peptide Vaccine Market

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.
Peptide Vaccine Market aims to provide a comprehensive presentation of the global market for Peptide Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Vaccine. Peptide Vaccine Market contains market size and forecasts of Peptide Vaccine in global, including the following market information:
Global Peptide Vaccine Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Peptide Vaccine Market Sales, 2018-2023, 2024-2030, (K Dose)
Global top five Peptide Vaccine companies in 2022 (%)
The global Peptide Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Solution Phase Synthesis (SPS) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptide Vaccine include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, Merck and ImmunoCellular Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peptide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Vaccine Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Peptide Vaccine Market Segment Percentages, by Type, 2022 (%)
Solution Phase Synthesis (SPS)
Solid Phase Peptide Synthesis (SPPS)
Global Peptide Vaccine Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Peptide Vaccine Market Segment Percentages, by Application, 2022 (%)
Prostate Cancer
Breast Cancer
Gastric Cancer
Lung Cancer
Pancreatic Cancer
Others
Global Peptide Vaccine Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Peptide Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peptide Vaccine revenues share in global market, 2022 (%)
Key companies Peptide Vaccine sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Peptide Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Vaccine, market overview.
Chapter 2: Global Peptide Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Peptide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptide Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.